Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
ablation, adjudicated, advice, agent, AICPA, aid, alive, Amedica, Ameritrade, angioplasty, Anneurx, appendage, arm, array, Arterial, artery, Atlantic, atrial, Automated, AVANCE, Aviir, Bachelor, balloon, Bellevue, Berkeley, bidirectional, Biodesign, biography, biology, biosurgical, Boston, bowel, built, CareDx, career, Carolina, Certificat, Charitable, Chicago, clarified, Clarifying, cliff, Clorox, closure, COBRA, collusion, Columbia, column, compatibility, constraint, Continucare, convergence, Cornell, CPA, criterion, cryopreserved, Cum, cytoplasmic, debilitating, depicted, depression, Deputy, disability, discretionary, distinct, Donald, electrophysiology, elegantly, Elevation, embolic, emphasize, endothelia, Epoch, EU, faulty, fertility, FESC, fibrillation, fibromyalgia, FINRA, foramen, Forum, fourteen, fullest, Genmark, glia, GP, grantor, Harvard, hearing, Hill, household, Humana, identification, immaterial, Imperva, indemnification, indemnify, inflammatory, insight, installed, IntegraMed, Interaction, Interactive, inventor, irrevocable, Irwin, ISO, Jose, Kenan, Kimberly, Krasno, Ladenburg, Laude, Lenox, lesser, literacy, lodging, LP, Lumen, lump, MACE, Master, Matson, Medtronic, Metropolitan, Milan, mitral, ml, Monterey, Moose, motivate, narrative, Navigation, network, neurology, neuropeptide, NeuroScience, neurovascular, NextWave, nominating, nomination, North, notable, Novare, Oncocyclist, online, ovale, override, pace, pacemaker, parachute, path, percentile, peripheral, Pesta, Pfizer, pharmacologist, Phil, Physiologie, Plant, plasma, Polymer, predecessor, prosthetic, protracted, Pulmonology, Puma, readout, receptor, resale, respiratory, rheumatological, Rock, Rotterdam, Rudolf, save, science, sensory, septal, serum, shipment, sickle, Singapore, SingXpand, Society, Sorbonne, South, SP, spent, staggered, startup, stay, Steel, StemXpand, stent, straightforward, Stryker, subpopulation, Substance, syncytial, TD, Thalmann, theoretical, Thoraxcenter, transsceptal, triple, unfold, Univ, unrestricted, Utah, Utecht, Utrecht, valve, Vanderbilt, variable, vein, Walter, Weber, white, Whitman, William, Wilson, Windrock, Wyoming, young
Removed:
absence, assured, attestation, buyer, deteriorate, higher, issuance, leased, preferred, proxy, surgery, twelve
Filing tables
Filing exhibits
BCDA similar filings
Filing view
External links
Exhibit 32.1
Certification of Principal Executive Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Peter Altman, the President and Chief Executive Officer of BioCardia, Inc. (the "Company"), hereby certify, that, to my knowledge:
1. The Annual Report on Form 10-K for the year ended December 31, 2018 (the "Report") of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: April 1, 2019
/s/ Peter Altman | ||
Name: Peter Altman | ||
Title: President and Chief Executive Officer |